Showing results (651-660 of 902) with videos related to

Sort By:
Pageof 91
Cancers|May 14, 2022
Spatial Characterization of Tumor-Infiltrating Lymphocytes and Breast Cancer ProgressionDanielle J Fassler, Luke A Torre-Healy, Rajarsi Gupta, et al.
Medical Care|June 19, 2013
Caveats for the use of operational electronic health record data in comparative effectiveness researchWilliam R Hersh, Mark G Weiner, Peter J Embi, et al.
Journal of Oncology Practice|June 5, 2014
Colorectal cancer survivors' needs and preferences for survivorship informationTalya Salz, Shrujal S Baxi, Victoria S Blinder, et al.
Translational Oncology|November 13, 2014
NCI Workshop Report: Clinical and Computational Requirements for Correlating Imaging Phenotypes with Genomics SignaturesRivka Colen, Ian Foster, Robert Gatenby, et al.
International Journal of Radiation Oncology, Biology, Physics|August 6, 2023
Compliance and Toxicity of Total Neoadjuvant Therapy for Rectal Cancer: A Secondary Analysis of the OPRA TrialFloris S Verheij, Dana M Omer, Sabrina T Lin, et al.
Clinical Colorectal Cancer|October 15, 2018
FOLFCIS Treatment and Genomic Correlates of Response in Advanced Anal Squamous Cell CancerSebastian Mondaca, Walid K Chatila, David Bates, et al.
The New England Journal of Medicine|September 28, 2000
Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. Irinotecan Study GroupL B Saltz, J V Cox, C Blanke, et al.
Annals of Surgery|June 6, 2012
Pulmonary recurrence predominates after combined modality therapy for rectal cancer: an original retrospective studyPeirong Ding, David Liska, Peter Tang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 29, 2013
Association of TP53 mutational status and gender with survival after adjuvant treatment for stage III colon cancer: results of CALGB 89803Robert S Warren, Chloe E Atreya, Donna Niedzwiecki, et al.
JCO Precision Oncology|January 29, 2019
Real-Time Genomic Characterization of Metastatic Pancreatic Neuroendocrine Tumors Has Prognostic Implications and Identifies Potential Germline ActionabilityNitya Raj, Ronak Shah, Zsofia Stadler, et al.
Pageof 91